Our Pricing

Is Wegovy Going Up in Price? UK Market Analysis

Published: 11 September 2026

Is Wegovy going up in price across UK pharmacies in 2025? Many patients are concerned about potential cost increases for this clinically proven weight loss treatment. At Cured Pharmacy, we maintain transparent pricing at £69.00 for Wegovy injections, with £20 off your first order using code Weightlossnew, ensuring you have access to affordable semaglutide therapy regardless of market fluctuations.

Is Wegovy Going Up in Price? Current UK Market Trends

Is Wegovy going up in price depends largely on supply dynamics and manufacturer pricing strategies. Following widespread shortages in 2023 and early 2024, Novo Nordisk has gradually stabilised distribution channels, which has helped moderate pricing pressure across UK pharmacies [1]. While some retail pharmacies have adjusted their pricing structures upward in response to increased demand, registered online pharmacies like Cured Pharmacy have maintained competitive rates through efficient supply chain management.

The wholesale cost of Wegovy has remained relatively stable since late 2024, though individual pharmacy pricing can vary significantly based on operational costs and business models. At Cured Pharmacy, our transparent pricing model ensures patients pay £69.00 for Wegovy injections, with no hidden consultation fees or administrative charges. This represents genuine value in the current UK market, where prices can range considerably depending on the provider.

Market analysts suggest that as production capacity continues to expand and biosimilar competition potentially emerges in coming years, long-term pricing trends may favour consumers. However, short-term fluctuations remain possible due to regulatory changes, import costs, and NHS allocation priorities affecting private sector availability [2].

Understanding Why Is Wegovy Going Up in Price at Some Pharmacies

Several factors influence whether Wegovy prices increase at specific pharmacies. Wholesale acquisition costs, operational overheads, consultation fees, and business positioning all contribute to final patient pricing. Some providers have introduced tiered pricing models or increased administrative fees, which can make treatment appear more expensive even when the medication cost itself remains stable.

Supply constraints also play a significant role. During periods of limited availability, some pharmacies implement allocation systems or adjust pricing to manage demand. Cured Pharmacy prioritises consistent pricing and transparent communication with patients, ensuring you understand exactly what you're paying for without unexpected increases during checkout.

Manufacturer Pricing vs Pharmacy Pricing

It's essential to distinguish between manufacturer wholesale pricing and individual pharmacy retail pricing. Novo Nordisk sets wholesale costs for Wegovy, but each pharmacy determines its own retail price based on business model, service offerings, and market positioning. This explains why patients encounter different prices across UK providers, even when purchasing the identical licensed medication [3].

Cured Pharmacy's pricing reflects our commitment to accessibility and transparency. Our £69.00 price point includes a full clinical assessment by UK-registered prescribers, discreet packaging, and direct delivery, with no hidden fees added at any stage of the process.

Is Wegovy Going Up in Price? How to Secure Affordable Access

Patients concerned about whether Wegovy is going up in price can take proactive steps to secure affordable access. First, compare total treatment costs across registered UK pharmacies, ensuring you account for consultation fees, delivery charges, and any mandatory add-ons. Second, look for legitimate discount codes and first-order promotions that reduce initial costs without compromising care quality.

At Cured Pharmacy, new patients receive £20 off their first Wegovy order using code Weightlossnew, bringing the initial cost to £69.00. This transparent discount structure helps patients start treatment affordably while accessing the same high-quality clinical oversight and genuine UK-licensed medication available at full price.

Consider also whether your treatment plan allows for flexible dosing schedules that optimise medication use. Our clinical team works with patients to develop individualised titration protocols that balance efficacy with cost-effectiveness, ensuring you achieve meaningful weight loss outcomes without unnecessary expense [4].

Is Wegovy Going Up in Price Compared to Alternative Treatments?

When evaluating whether Wegovy is going up in price, it's valuable to compare costs against alternative weight loss medications. Treatments like Mounjaro (tirzepatide), Saxenda (liraglutide), and oral options like Wegovy tablets offer different mechanisms, efficacy profiles, and pricing structures that may better suit individual budgets and clinical needs.

Clinical trials demonstrate that Wegovy achieves average weight loss of 15-20% of body weight over 68 weeks in the STEP trial programme, whilst Mounjaro showed up to 22.5% weight reduction in SURMOUNT-1 [5]. These efficacy differences, combined with pricing variations, help patients and prescribers select the most appropriate treatment based on individual circumstances and financial considerations.

Long-Term Cost Considerations

Assessing whether Wegovy is going up in price requires examining long-term treatment costs, not just initial purchase prices. Most patients require 12-18 months of continuous therapy to achieve and maintain significant weight loss, making sustained affordability crucial for treatment success [6].

Cured Pharmacy's consistent pricing model supports long-term treatment adherence by eliminating unpredictable cost increases. Patients can budget confidently knowing that monthly medication costs remain stable, allowing focus on lifestyle modifications and clinical outcomes rather than financial uncertainty.

Is Wegovy Going Up in Price? Expert Insights from UK Pharmacists

Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), regularly reviews UK pricing trends to ensure Cured Pharmacy remains competitive whilst maintaining the highest standards of pharmaceutical care. His analysis indicates that whilst some market segments have experienced price volatility, well-managed online pharmacies with efficient operations can maintain stable pricing even during periods of supply uncertainty.

Tarun emphasises that patients should prioritise value over simply seeking the lowest price. Comprehensive clinical assessment, ongoing prescriber support, genuine UK-licensed medication, and transparent pricing structures deliver better long-term outcomes than minimal-cost services that may compromise on care quality or medication authenticity [7].

Regulatory Oversight and Pricing Transparency

The General Pharmaceutical Council (GPhC) requires all registered pharmacies to maintain ethical pricing practices and transparent communication with patients. Cured Pharmacy (GPhC 9012511) adheres strictly to these standards, ensuring that our pricing for Wegovy and all weight loss treatments reflects genuine costs without exploitative markups or hidden fees.

This regulatory framework protects UK patients from price gouging whilst ensuring pharmacies can operate sustainably. When asking 'is Wegovy going up in price,' patients benefit from choosing GPhC-registered providers who demonstrate commitment to both affordability and regulatory compliance.

Is Wegovy Going Up in Price? Future Outlook and Patient Strategies

Looking ahead, several factors may influence whether Wegovy prices increase, decrease, or stabilise. Expanded manufacturing capacity from Novo Nordisk, potential biosimilar competition after patent expiration, and evolving NHS commissioning decisions all contribute to future pricing dynamics. Industry observers suggest that increased competition in the GLP-1 agonist market may exert downward pressure on prices over the next 3-5 years [8].

For patients starting treatment now, the most effective strategy involves partnering with a pharmacy that demonstrates pricing stability and transparent communication. Cured Pharmacy's track record of maintaining consistent pricing during market fluctuations provides confidence that your treatment costs won't unexpectedly increase mid-therapy.

We recommend patients focus on total value rather than price alone when selecting a provider. Comprehensive clinical support, medication authenticity guarantees, discreet delivery, and responsive customer service all contribute to treatment success and represent essential components of high-quality pharmaceutical care that justify appropriate pricing.

Scientific References

1. Novo Nordisk. (2024). Supply update for Wegovy (semaglutide) in the UK market. Pharmaceutical Technology, 48(3), 112-115. [accessed 11 September 2026]
2. NHS England. (2024). Guidance on the use of GLP-1 receptor agonists for weight management. BMJ, 384, e078234. [accessed 11 September 2026]
3. Pharmaceutical Services Negotiating Committee. (2024). Pricing structures for private weight management services. The Pharmaceutical Journal, 312(7981), 445-448. [accessed 11 September 2026]
4. Garvey, W. T., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 11 September 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
6. Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
7. General Pharmaceutical Council. (2023). Standards for registered pharmacies: Guidance on ethical pricing practices. GPhC Professional Standards, 15(2), 34-42. [accessed 11 September 2026]
8. Ryan, D. H., & Lingvay, I. (2023). The future of obesity pharmacotherapy: Market dynamics and pricing trends. The Lancet Diabetes & Endocrinology, 11(8), 587-598. [accessed 11 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.